BGSRX
Price
$77.17
Change
+$1.03 (+1.35%)
Updated
Jul 31 closing price
Net Assets
7.51B
PRGTX
Price
$33.21
Change
+$0.39 (+1.19%)
Updated
Jul 31 closing price
Net Assets
7.92B
Interact to see
Advertisement

BGSRX vs PRGTX

BGSRX vs PRGTX Comparison Chart in %
View a ticker or compare two or three
VS
BGSRX vs. PRGTX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGSRX is a Buy and PRGTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRGTX has more cash in the bank: 7.92B vs. BGSRX (7.51B). BGSRX pays higher dividends than PRGTX: BGSRX (1.03) vs PRGTX (0.00). BGSRX was incepted earlier than PRGTX: BGSRX (18 years) vs PRGTX (26 years). BGSRX (1.53) is less costly to investors than PRGTX (0.93). BGSRX is a more actively managed with annual turnover of: 52.00 vs. PRGTX (34.60). BGSRX has a lower initial minimum investment than PRGTX: BGSRX (100) vs PRGTX (2500). PRGTX annual gain was more profitable for investors over the last year : 39.13 vs. BGSRX (12.40). BGSRX return over 5 years is better than : 24.04 vs. PRGTX (5.19).
BGSRXPRGTXBGSRX / PRGTX
Total Expense Ratio1.390.93149%
Annual Report Gross Expense Ratio1.530.93165%
Fund Existence18 years26 years-
Gain YTD12.01925.08548%
Front LoadN/AN/A-
Min. Initial Investment10025004%
Min. Initial Investment IRAN/AN/A-
Net Assets7.51B7.92B95%
Annual Yield % from dividends1.030.00-
Returns for 1 year12.4039.1332%
Returns for 3 years63.53126.2350%
Returns for 5 years24.045.19463%
Returns for 10 years363.06134.04271%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSVVX5.540.02
+0.36%
MetLife Small Company Equity Investor
ETLAX16.810.06
+0.36%
Eventide Large Cap Focus A
SABTX29.750.08
+0.27%
SA US Value
VSNGX69.90-0.18
-0.26%
JPMorgan Mid Cap Equity I
ETCHX48.36-0.79
-1.61%
Eventide Healthcare & Life Sciences C